Literature DB >> 14534609

Content of autoantibodies to bradykinin and beta-amyloid(1-42) as a criterion for biochemical differences between Alzheimer's dementias.

M A Myagkova1, S I Gavrilova, N N Lermontova, Ya B Kalyn, N D Selezneva, G A Zharikov, I V Kolykhalov, T V Abramenko, T P Serkova, S O Bachurin.   

Abstract

We measured serum content of autoantibodies to beta-amyloid protein Abeta(1-42), its neurotoxic fragment Abeta(25-35), vasopressin, bradykinin, thrombin, antithrombin III, alpha(2)-macroglobulin, and angiotensin II in patients with various forms of Alzheimer's dementias, including presenile and senile dementias of the Alzheimer type. The ratio of antibradykinin and anti-Abeta(1-42) autoantibody contents differed by 39% in these patients. Our results can be used for the development of a new biochemical method for differential diagnostics of dementias of the Alzheimer type.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14534609     DOI: 10.1023/a:1026036829237

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  3 in total

Review 1.  T-cells in Alzheimer's disease.

Authors:  Terrence Town; Jun Tan; Richard A Flavell; Mike Mullan
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 2.  Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

Authors:  Kavon Rezai-Zadeh; David Gate; Christine A Szekely; Terrence Town
Journal:  Expert Rev Neurother       Date:  2009-11       Impact factor: 4.618

3.  Autoantibodies against appetite-regulating peptide hormones and neuropeptides: putative modulation by gut microflora.

Authors:  Sergueï O Fetissov; Maria Hamze Sinno; Moïse Coëffier; Christine Bole-Feysot; Philippe Ducrotté; Tomas Hökfelt; Pierre Déchelotte
Journal:  Nutrition       Date:  2008-02-08       Impact factor: 4.008

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.